Twin Reversal Arterial Perfusion Syndrome

2

Review clinical trials related to Twin Reversal Arterial Perfusion Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

In this research study, the investigators want to learn more about the role of new innovative surgical devices, the Karl Storz Curved and Straight Fetoscopes for in-utero surgery. A fetoscope is like a small telescope that can see inside of the uterus (womb) during minimally invasive surgery. The curved scope is used for patients with an anterior placenta (front of uterus), while the straight scope is used for patients with a posterior placenta (back of uterus). The scopes will be used to assist in procedures involving fetoscopic laser photocoagulation (FLP), which is a minimally invasive surgery that uses a small camera (fetoscope) to locate abnormal blood vessel connections in the placenta and seal them off using laser energy. These fetoscopes will be utilized in the diagnosis and management of various fetal conditions that can arise during pregnancy. Outcome data will be reported in a descriptive statistical analysis. The investigators will assess the surgical outcomes, short and long-term morbidity, complications, and gestational age of participants in order to evaluate the benefit of using these devices.

Participants needed: 50
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Boston Children's HospitalUpdated: Sep 25, 2024Locations: 1
Eligibility criteria

Pregnant patient with a condition requiring in-utero surgery [+2]

Allergy or previous adverse reaction to any ancillary medication specified in th... [+6]

Status: Recruiting

TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Multi-center open-label randomized controlled trial to assess if early intervention (12.0-14.0 weeks) (study group) improves the outcome of TRAP sequence as compared to late intervention (16.0-19.0 weeks) (control group). The investigators will randomly assign women diagnosed with TRAP sequence diagnosed between 12.0 and 13.6 weeks to an early or late intervention group (1:1), using a web-based application and a computer-generated list with random permuted blocks of sizes 2 or 4 (www.sealedenvelope.com), stratified by gestational age (GA) at inclusion (11.6 -12.6 weeks versus 13.0-13.6 weeks). Analysis will be by intention to treat.

Participants needed: 126
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Universitaire Ziekenhuizen KU LeuvenUpdated: Jul 10, 2024Locations: 14
Eligibility criteria

TRAP sequence in a monochorionic diamniotic twin pregnancy diagnosed between 11.... [+3]

Contraindication for an intervention due to a severe maternal medical condition... [+3]